Literature DB >> 16104005

Combined chemotherapy and teratogenicity.

Giorgio Adriano Paskulin1, Paulo Ricardo Gazzola Zen, Louise Lapagesse de Camargo Pinto, Rafael Rosa, Carla Graziadio.   

Abstract

BACKGROUND: The concomitant occurrence of breast cancer and pregnancy is relatively uncommon. We report the case of a patient with syndactyly, cleft hands, and absence of distal finger phalanges associated with maternal exposure to chemotherapeutic agents during the first trimester of pregnancy. These associations have not been previously described. CASE: The patient was born by normal delivery after 38 weeks of pregnancy. His mother became pregnant while receiving chemotherapy (cyclophosphamide, 5-fluorouracil, and adriamycin) for breast cancer, and the fetus was exposed to these drugs from conception to the 16th week of pregnancy. At birth, anomalies were observed, including a high-arched palate, microcephaly, a flat nasal bridge, bilateral syndactyly in the first and second fingers with a hand cleft between the second and third fingers and hypoplasia of the fifth fingers, and dystrophic nail of the fourth finger of the left hand. The patient's growth and development were deficient.
CONCLUSIONS: The malformations associated with in utero exposure to these chemotherapeutic agents are highly variable, but growth deficiency and anomalies of the craniofacial region and limbs are the most common. The pattern of malformations in children who were congenitally exposed to chemotherapeutic agents appears to be directly related to the age at and duration of exposure, rather than to the specific drug itself. Effective contraception is essential for the safe use of a potential teratogen in nonpregnant women of reproductive age. Birth Defects Research (Part A), 2005. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104005     DOI: 10.1002/bdra.20180

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  8 in total

1.  Fetal Renal Insufficiency Following Trastuzumab Treatment for Breast Cancer in Pregnancy: Case Report und Review of the Current Literature.

Authors:  Ingo Gottschalk; Christoph Berg; Nadia Harbeck; Rüdiger Stressig; Peter Kozlowski
Journal:  Breast Care (Basel)       Date:  2011-12-16       Impact factor: 2.860

2.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

Review 3.  Multidisciplinary Management of Breast Cancer During Pregnancy.

Authors:  Shlomit Strulov Shachar; Kristalyn Gallagher; Kandace McGuire; Timothy M Zagar; Aimee Faso; Hyman B Muss; Raeshall Sweeting; Carey K Anders
Journal:  Oncologist       Date:  2017-02-23

Review 4.  Is it safe for pregnant health-care professionals to handle cytotoxic drugs? A review of the literature and recommendations.

Authors:  S Gilani; S Giridharan
Journal:  Ecancermedicalscience       Date:  2014-04-10

Review 5.  Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?

Authors:  Nabil Abdalla; Magdalena Bizoń; Robert Piórkowski; Paweł Stanirowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Biomed Res Int       Date:  2017-05-24       Impact factor: 3.411

6.  Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.

Authors:  Mathilde van Gerwen; Charlotte Maggen; Elyce Cardonick; Emma J Verwaaijen; Marry van den Heuvel-Eibrink; Roman G Shmakov; Ingrid Boere; Mina M Gziri; Petronella B Ottevanger; Christianne A R Lok; Michael Halaska; Long Ting Shao; Ilana Struys; Elisabeth M van Dijk-Lokkart; Kristel Van Calsteren; Robert Fruscio; Paolo Zola; Giovanna Scarfone; Frédéric Amant
Journal:  JAMA Netw Open       Date:  2021-06-01

7.  Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care.

Authors:  Richard J Epstein
Journal:  BMC Cancer       Date:  2007-05-30       Impact factor: 4.430

Review 8.  Cancer treatment in pregnant women.

Authors:  Pawel Basta; Anna Bak; Krzysztof Roszkowski
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.